La Marató funds six IGTP research projects on respiratory diseases
Funds raised during the 2024 edition of La Marató de 3Cat, dedicated to respiratory diseases, will finance 36 research projects led by 60 research teams. These resources, totalling over 10 million euros, will contribute in the coming years to improving the understanding, diagnosis and treatment of a group of diseases that affect more than two million people in Catalonia and are the third leading cause of death in the country.
The Germans Trias i Pujol Research Institute (IGTP) has obtained funding for six projects, consolidating its trajectory in the field of biomedical and translational research on respiratory diseases. These projects, which address challenges such as tuberculosis, pulmonary fibrosis and legionellosis, represent the excellence and diversity of the research developed at the Can Ruti Campus.
Altogether, projects led by IGTP researchers have received over €1.3 million, an investment that will further the understanding of the biological, clinical and epidemiological mechanisms underlying several high-incidence respiratory diseases.
IGTP projects funded by La Marató 2024
Transforming pneumonia treatment: nanocarriers with miRNAs for immunomodulation and lung repair (Carri-Air)
- Dr Irene Aldás Criado, IGTP
- In collaboration with Dr Aina Areny Balagueró (I3PT) and Dr Juan Pellico Sáez (ICMAB-CSIC)
- Funding: €398,836
Towards real-time genomic epidemiology for better control of Mycobacterium tuberculosis transmission in Catalonia (fasTB-SEQ)
- Dr Pere-Joan Cardona i Iglesias, IGTP
- Funding: €199,266
Impact of haematopoiesis on tissue regeneration and pulmonary fibrosis
- Dr Raquel Guillamat Prats, IGTP
- Funding: €184,375
New insights into immunity and host-pathogen interactions in the tuberculosis spectrum (TB-SPECTRUM)
- Dr Irene Latorre Rueda, IGTP
- Funding: €199,971
Legionellosis in Catalonia: an intervention study on diagnostic methodology
- Dr Noemí Párraga Niño, IGTP
- Funding: €139,158
Deciphering a complex dance: exploring the dynamic interplay between pulmonary fibrosis and lung cancer pathways (FIBROCAN)
- Dr Karina Portillo Carroz, IGTP
- Funding: €188,125
The announcement made yesterday by the La Marató de 3Cat Foundation marks the start of a new stage for respiratory health research in Catalonia, with the participation of 502 professionals from 60 research teams. The evaluation of the projects was coordinated by the Catalan Agency for Health Quality and Assessment (AQUAS), which led an international peer-review process involving 93 experts in the field.
Since its creation, La Marató has funded 1,084 research projects, promoted by more than 1,800 research teams and nearly 12,000 researchers, making a decisive contribution to scientific and medical progress in our country.